St. Luke’s University Health Network reports positive results with Provectus Biopharmacueticals’ PV-10 investigational treatment as “the tumors simply shriveled up and flaked off.” Background of PV-10 St. Luke’s University Health Network in Pennsylvania is conducting...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
